Dr. Sami Mohamad Aboumatar, MD

Dr. Aboumatar practices at St. David's Medical Center in Austin, Texas, part of HCA Healthcare.

Dr. Aboumatar's NPI, 1760445407, was assigned on April 11, 2006. Dr. Aboumatar graduated from American University of Beirut Faculty of Medicine in 1992. Dr. Aboumatar holds Texas license L6748.

Dr. Aboumatar's primary practice is St. David's Medical Center, at 919 E 32nd St, Austin, TX 78705 in Travis County. The practice phone is (512) 476-7111.

Dr. Aboumatar's primary practice is St. David's Medical Center in Austin, Texas, part of HCA Healthcare. Dr. Aboumatar is also affiliated with St. David's North Austin Medical Center. The medical group on file is Austin Epilepsy Care Center. Dmand AI also links Dr. Aboumatar to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aboumatar practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Aboumatar's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Aboumatar is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Aboumatar's licenses on file in 5 states: Texas, New York, New Jersey, Indiana and Ohio.

Dmand AI lists acute mini-stroke (TIA), epilepsy, fibromyalgia and chronic pain, hereditary polyneuropathy, migraine and chronic headache, mobility impairment, neuropathy and seizures among the conditions Dr. Aboumatar treats.

CMS data shows 1,216 Medicare services from Dr. Aboumatar across 13 procedure codes in 2024, for 386 Medicare patients. Medicare paid $126,832 for them.

CMS counts 386 Medicare patients who saw Dr. Aboumatar in 2024. The largest group is 65 to 74, with 152 patients. 64% of them have high cholesterol, and 57% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Aboumatar's median patient age at 49, with 54% women.

In 2024, Dr. Aboumatar wrote 8,995 Medicare Part D claims for 645 patients. 80% of them were for generic drugs. CMS names the drug for 8,716 of them, across 83 drugs with 11 or more claims each, at $3,973,560 in total drug cost. In 2023, CMS named 7,922 claims across 85 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Aboumatar for performance year 2024, reported individually. Dr. Aboumatar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Aboumatar as offering telehealth.

Dmand AI links 11 papers to Dr. Aboumatar, published from 2020 to 2024. 2022 was the busiest year, with 5. The most frequent topics are Anticonvulsants, Seizures and Double-Blind Method. Dr. Aboumatar has published most often in Epilepsia. Dr. Aboumatar's most frequent co-authors are William Elliot Rosenfeld, MD, Robert T. Wechsler, MD, PhD and Gregory L. Krauss, MD.

Dmand AI links Dr. Aboumatar to 2 clinical trials. Conditions studied include Epilepsy, Epilepsies, Partial and Brain Diseases.

CMS Open Payments shows 745 general payments to Dr. Aboumatar from 50 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 36% of the total. SK Life Science, Inc. paid the most, $45,203. It also lists 59 research payments totaling $32,605 from 2019 to 2025.

Dmand AI lists 1 award for Dr. Aboumatar, most recently CMS Stage 1 EHR in 2013.

Dr. Aboumatar graduated from American University of Beirut Faculty of Medicine in 1992.

Dr. Aboumatar is in network with 17 carriers, including Aetna, United Healthcare and HCSC. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.